Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Patients at risk for developing heart failure with preserved ejection fraction (HFpEF) will undergo a structured clinical assessment, transthoracic echocardiography and pulse-wave analysis to investigate the association of arterial stiffening and the development of cardiac diastolic dysfuntion and HFpEF.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

⁃ One or more of the following criteria:

• Age \> 60 years

• Arterial hypertension (RR systolic ≥ 140 mmHg or diastolic ≥ 90 mmHg or ≥ 2 antihypertensive drugs)

• Diabetes mellitus Type I or II

• Atrial fibrillation

• Chronic kidney disease (GFR \< 60 ml/min/1,73 m2 or urine albumin ≥ 30mg/24h or ACR ≥ 30 mg/g)

• BMI ≥ 30 kg/m2

• NYHA ≥ II

• E/e' \> 8

Locations
Other Locations
Germany
Universitätsmedizin Göttingen
RECRUITING
Göttingen
Time Frame
Start Date: 2024-02-23
Estimated Completion Date: 2028-01
Participants
Target number of participants: 150
Sponsors
Leads: University Medical Center Goettingen

This content was sourced from clinicaltrials.gov